These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus. Ashraf-Uz-Zaman M; Li X; Yao Y; Mishra CB; Moku BK; Song Y J Med Chem; 2023 Aug; 66(15):10746-10760. PubMed ID: 37506506 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus. Pitts JD; Li PC; de Wispelaere M; Yang PL Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection. Chuang FK; Huang SM; Liao CL; Lee AR; Lien SP; Chiu YL; Chang TH; Tsai PL; Lin RJ; Shih CC; Tsai YJ; Lin GJ; Yen LC Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636070 [TBL] [Abstract][Full Text] [Related]
9. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds. Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo. Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029 [TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection. Kim SY; Koetzner CA; Payne AF; Nierode GJ; Yu Y; Wang R; Barr E; Dordick JS; Kramer LD; Zhang F; Linhardt RJ Biochemistry; 2019 Feb; 58(8):1155-1166. PubMed ID: 30698412 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection. Loe MWC; Lee RCH; Chu JJH Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333 [TBL] [Abstract][Full Text] [Related]
13. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion. Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene Nanoballs for Emergent Viruses. Ramos-Soriano J; Reina JJ; Illescas BM; de la Cruz N; Rodríguez-Pérez L; Lasala F; Rojo J; Delgado R; Martín N J Am Chem Soc; 2019 Sep; 141(38):15403-15412. PubMed ID: 31469952 [TBL] [Abstract][Full Text] [Related]
15. Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. Vicenti I; Dragoni F; Giannini A; Giammarino F; Spinicci M; Saladini F; Boccuto A; Zazzi M SLAS Discov; 2020 Jun; 25(5):506-514. PubMed ID: 32186426 [TBL] [Abstract][Full Text] [Related]
16. A Review of the Ongoing Research on Zika Virus Treatment. da Silva S; Oliveira Silva Martins D; Jardim ACG Viruses; 2018 May; 10(5):. PubMed ID: 29758005 [TBL] [Abstract][Full Text] [Related]
17. The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Wilken L; Rimmelzwaan GF; Elbahesh H J Virol; 2024 Aug; 98(8):e0061824. PubMed ID: 39023323 [TBL] [Abstract][Full Text] [Related]
18. Haddad JG; Koishi AC; Gaudry A; Nunes Duarte Dos Santos C; Viranaicken W; Desprès P; El Kalamouni C Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091703 [TBL] [Abstract][Full Text] [Related]
19. Identification of Inhibitors of ZIKV Replication. Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956 [TBL] [Abstract][Full Text] [Related]
20. Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections. Chen WC; Simanjuntak Y; Chu LW; Ping YH; Lee YL; Lin YL; Li WS J Med Chem; 2020 Feb; 63(3):1313-1327. PubMed ID: 31972088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]